ClinicalTrials.Veeva

Menu

Pathophysiological Explorations of Red Blood Cells (GR-Ex)

I

Imagine Institute

Status

Enrolling

Conditions

Red Blood Cell Disorder

Treatments

Other: Biological sampling

Study type

Observational

Funder types

Other

Identifiers

NCT03541525
IMNIS2015-04

Details and patient eligibility

About

GR-Ex is a program labelled by Labex (Laboratory of Excellence) by the French Ministry of Higher Education and Research. This program aims to develop the means to improve knowledge in the physiology and pathologies of erythropoiesis, red blood cells and iron metabolism, and to develop new therapeutic protocols capable of providing added value in terms of innovation.

Enrollment

3,750 estimated patients

Sex

All

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • To be affected or have a family history of disease bound to the red blood cell,
  • For adult subjects, have signed an informed consent form,
  • For minor or major under legal safeguard subjects, the form must be signed by both parents (for minors) or by the legal representative,
  • Be affiliated to health insurance.

Exclusion criteria

  • Being deprived of freedom

Trial design

3,750 participants in 2 patient groups

Affected patients
Description:
Biological samples of blood for all patients. Biological samples of saliva, surgical remainder (skin, tumor, kidney,....), saliva, urine, hair.
Treatment:
Other: Biological sampling
Non affected relatives
Description:
Biological samples of blood for all relatives.
Treatment:
Other: Biological sampling

Trial contacts and locations

25

Loading...

Central trial contact

Sandra Manceau, PhD; Pierre Buffet, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems